ANI Pharmaceuticals | ANIP - Current Assets


ANI Pharmaceuticals reported $747.08M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
ANI Pharmaceuticals USD 747.08M 6.03M Mar/2026
Aurora Cannabis CAD 397.45M 48.38M Mar/2026
Canopy Growth CAD 529.47M 4.8M Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Heron Therapeutics USD 228.98M 9.08M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Omeros USD 69.65M 26.53M Jun/2025
Perrigo USD 2.71B 85M Mar/2026
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026